Intrinsic value of Supernus Pharmaceuticals, Inc. (SUPN)
Live fair value data for Supernus Pharmaceuticals, Inc. (SUPN) is currently unavailable. Please check again shortly.
Current Price: $396.00
Valuation: Undervalued
Confidence: 8.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Supernus Pharmaceuticals, Inc. (SUPN) undervalued or overvalued?
Based on the current model output, Supernus Pharmaceuticals, Inc. appears to be undervalued with a upside of 44.00%.
Fair value vs market price — Supernus Pharmaceuticals, Inc. (SUPN)
Unlock premium access to view the live fair value comparison against current market price for SUPN.
Frequently Asked Questions - SUPN
How is SUPN intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for SUPN.
Is SUPN undervalued or overvalued right now?
SUPN is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for SUPN: open their intrinsic value pages.